Literature DB >> 1487455

Effects of propafenone on function and metabolism in the ischemic working rat heart.

T Nakamura1, S Kashimoto, T Oguchi, T Kumazawa.   

Abstract

We examined the effects of propafenone, a new anti-dysrhythmic agent, on myocardial function and metabolism in ischemic working rat heart preparations. In the treated hearts, propafenone, 0.3 micrograms/ml and 3 micrograms/ml, were added to Krebs-Henseleit bicarbonate buffer perfusate throughout the experiments. Whole heart ischemia was induced through a one-way aortic valve for 15 min followed by 'reperfusion for 30 min. After induction of ischemia, the cardiac output, peak aortic systolic pressure, left ventricular dP/dtmax, and myocardial ATP concentration were greater in the treated hearts than in the untreated ones. All hearts in the untreated group developed ventricular fibrillation (Vf) at the beginning of the reperfusion period. On the other hand, no treated hearts had Vf at any time during the experiment. However, propafenone, 3 micrograms/ml, evoked a negative inotropic effect before and after ischemia. These results indicate that propafenone may contribute to early recovery from ischemia in myocardial function and metabolism, although it has a negative inotropic action.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1487455     DOI: 10.1007/bf01744601

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  12 in total

1.  [New values for the molar extinction coefficients of NADH and NADPH for the use in routine laboratories (author's transl)].

Authors:  H U Bergmeyer
Journal:  Z Klin Chem Klin Biochem       Date:  1975-11

2.  The multiple modes of action of propafenone.

Authors:  I D Dukes; E M Vaughan Williams
Journal:  Eur Heart J       Date:  1984-02       Impact factor: 29.983

3.  Suppression of ventricular arrhythmias by propafenone, a new antiarrhythmic agent, during acute myocardial infarction in the conscious dog. A comparative study with lidocaine.

Authors:  H S Karagueuzian; T Fujimoto; T Katoh; T Peter; A McCullen; W J Mandel
Journal:  Circulation       Date:  1982-12       Impact factor: 29.690

4.  Electrophysiologic effects of propafenone on canine ischemic cardiac cells.

Authors:  R H Zeiler; W B Gough; N El-Sherif
Journal:  Am J Cardiol       Date:  1984-08-01       Impact factor: 2.778

5.  Propafenone: a new agent for ventricular arrhythmia.

Authors:  P J Podrid; B Lown
Journal:  J Am Coll Cardiol       Date:  1984-07       Impact factor: 24.094

6.  Aggravation of electrically provoked ventricular tachycardia during treatment with propafenone.

Authors:  C S Stavens; B McGovern; H Garan; J N Ruskin
Journal:  Am Heart J       Date:  1985-07       Impact factor: 4.749

7.  Electrophysiologic and hemodynamic effects of intravenous propafenone in patients with recurrent ventricular tachycardia.

Authors:  E N Shen; R J Sung; F Morady; A B Schwartz; M M Scheinman; L DiCarlo; W Shapiro
Journal:  J Am Coll Cardiol       Date:  1984-05       Impact factor: 24.094

8.  Effect of propafenone on the membrane currents of rabbit sino-atrial node cells.

Authors:  H Satoh; K Hashimoto
Journal:  Eur J Pharmacol       Date:  1984-03-23       Impact factor: 4.432

9.  Electrophysiological and antiarrhythmic properties of propafenon in isolated cardiac preparations.

Authors:  F Ledda; L Mantelli; S Manzini; S Amerini; A Mugelli
Journal:  J Cardiovasc Pharmacol       Date:  1981 Nov-Dec       Impact factor: 3.105

10.  European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.

Authors:  P Coumel; J F Leclercq; P Assayag
Journal:  Am J Cardiol       Date:  1984-11-14       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.